Evercore ISI assumes LiveRamp stock coverage with outperform rating

Evercore ISI initiated/maintained an outperform on LiveRamp with a $37 price target (current $27.41), implying ≈35% upside; Benchmark raised its target to $40. Board approved a $200M increase to the buyback program (total authorization $1.5B, ~$337M available through end-2027). Company fundamentals show 9.2% LTM revenue growth and 70.4% gross margin, trading at 8.1x CY2026 EV/FCF and 1.6x CY2026 EV/Sales; Evercore expects revenue to accelerate from high single digits in FY26 to low double digits in FY27–28. Strategic positives include an AI partnership with Scowtt and a board appointment (Kristi Argyilan); one director resigned with no stated disagreements.

Analysis

LiveRamp’s momentum should be viewed through two structural vectors: accelerating demand for privacy-safe clean rooms (higher wallet share from retailers/CPGs) and AI-driven ad optimization that raises per-client ARPU once predictive models are embedded. The Scowtt integration is a classic durability accelerator — marginal customer value rises with more predictive signals, increasing switching costs and lifting gross retention over 12–24 months.

Second-order winners include high-performance compute and data-infrastructure providers that service on-prem/colocated clean rooms; expect incremental backlog opportunities for those vendors as customers prioritize latency and model training. Conversely, layering predictive optimization into audience pipelines compresses margins for low-value ad networks and some programmatic middlemen, creating potential consolidation targets over the next 2–3 years.

Primary near-term risks are macro-driven ad pullbacks and regulatory moves that restrict cross-context identity resolution; both can compress bookings and delay the margin cadence management is guiding toward. Key catalysts to watch over the next 2 quarters are (a) measurable client rollouts of the predictive module, (b) sequential bookings and retention updates, and (c) cadence and velocity of buyback execution — any of which can re-rate the multiple materially in either direction.

Key Decisions for Investors

• Long RAMP equity on patient pullback: accumulate into a -12% to -20% intraday or multi-week drawdown, target 40–60% upside over 12–24 months driven by ARPU expansion and buyback-driven EPS accretion; hard stop at -25% from entry to control execution risk.
• Directional options (defined-risk): buy 12–18 month RAMP call spreads sized at 2–3% portfolio risk (pay premium = max loss). Use spreads to capture asymmetric upside if quarterly integrations show customer adoption; elect to exercise or roll on strong bookings beats.
• Pair trade to isolate identity vs user-acquisition cyclicality: long RAMP / short APP (equal notional) for 6–12 months. Rationale: RAMP benefits from structural identity/retail-media secular growth while APP is more exposed to cyclical UA ad spend — expect positive carry if ad budgets reallocate to measurement/targeting.
• Income overlay post-entry: once long RAMP, sell 3–6 month covered calls at a modest premium to reduce basis if near-term catalysts are uncertain; reassess after each quarterly print and buyback disclosure.
• Watch-list/trigger: short ad-network or DSP names that report sequential bookings misses or public client churn within 30 days of RAMP customer wins (trade window 0–90 days from announcement) — these are tactical opportunities to capture dispersion between winners and laggards.